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Aim: The aim of this study was to investigate the effect of nesfatin-1 signaling in the
ventromedial hypothalamus (VMH) on gastric functions, as well as the regulation of these
effects by nucleus accumbens (NAc) projections to VMH.
Methods: The expression of c-fos in nesfatinergic VMH neurons induced by gastric
distension (GD) was measured using the double fluoro-immunohistochemical staining.
The firing rates of neurons were monitored with single-unit extracellular electric discharge
recording. The projection of nesfatinergic neurons from NAc to VMH was observed by
fluorogold retrograde tracer combined with fluoro-immunohistochemical staining. The
effect of nesfatin-1 in VMH or electric stimulation in NAc on gastric function was studied
by measuring food intake, gastric acid output, gastric motility, and gastric emptying, and
the ability of the melanocortin-3/4 receptor antagonist SHU9119 or the anti-nesfatin-1
antibody to block nesfatin-1 in the VMH was assessed.
Results: Expression of c-fos was observed in VMH nesfatinergic neurons following GD
in rats. Further, nesfatin-1 delivery to single GD-responsive neurons changed the firing
rates of these neurons in the VMH. In awake, behaving rats, intra-VMH administration
of nesfatin-1 inhibited food intake, gastric acid output, gastric motility, and gastric
emptying. These effects were abolished by SHU9119. Fluorogold retrograde tracing
showed nesfatinergic neural projection from the NAc to the VMH. Electrical stimulation
of NAc modified the firing rates of the VMH neurons and inhibited food intake and gastric
functions. The pretreatment with an anti-nesfatin-1 antibody in the VMH reversed the
effects of NAc electrical stimulation on the VMH neuronal firing rates and gastric function.
Conclusions: Nesfatin-1 in the VMH inhibited food intake, gastric acid output,
gastric motility, and gastric emptying. A nesfatinergic pathway between NAc and VMH
transmitted metabolism-regulating signals.
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INTRODUCTION
Obesity is widely regarded as an important public health
problem throughout the developed world (Ng et al., 2014). Food
intake is controlled by multiple neurochemical and endocrine
signaling systems including several neuropeptides. Nesfatin-1,
one of the few anorexigenic neuropeptides, has received much
recent focus for its role in regulating food intake (Oh et al.,
2006; Maejima et al., 2009). Nesfatin-1 is derived from the
precursor nucleobindin-2 (NUCB2) and expressed in the nucleus
accumbens (NAc), paraventricular nucleus (PVN), ventromedial
hypothalamus (VMH), and arcuate nucleus (ARC), among other
brain nuclei (Oh et al., 2006; Goebel et al., 2009). Experimentally,
intracerebroventricular (i.c.v.) or intravenous (i.v.) injection of
nesfatin-1 in rats decreases food intake and body weight via a
leptin-independent, melanocortin-dependent signaling pathway
(Oh et al., 2006; Maejima et al., 2009).
Earlier studies used i.c.v. administration of nesfatin-1, so the
brain nucleus or nuclei responsible for these effects is not known.
Further, the receptor for nesfatin-1 is yet unknown, making a
mechanistic understanding of nesfatin-1 signaling in the central
nervous system difficult to ascertain. To begin to answer these
questions, we have injected nesfatin-1 in PVN and ARC (Li et al.,
2013; Guo et al., 2015), and found that nesfatin-1 signaling in
these areas has an inhibitory role in gastric motility. Moreover,
these effects were caused by nesfatinergic projections from lateral
hypothalamic area (LHA) to PVN or from PVN to ARC.
The VMH plays a key role in the regulation of feeding
behaviors and themediation of satiety (Duggan and Booth, 1986).
In rats, VMH lesion enhances mRNA and protein expression
of nesfatin-1 in white adipose tissues, stomach, and duodenum,
as well as increases gastric emptying (Osaki et al., 2012; Tian
et al., 2014). However, it is not known if the expression of
nesfatin-1 in the VMH is affected by feeding and if injection
of nesfatin-1 in the VMH modifies gastric function. Based on
the anorexigenic role of nesfatin-1 and the satiety signals from
VMH to the gastrointestinal tract, our hypothesis is that nesfatin-
1 might be a “satiety” transmitter in the VMH and might play an
important role in inhibiting gastric motility, emptying, and acid
secretion.
Beside the direct regulation of the digestive system, the brain
also influences food intake through reward mechanisms that are
necessary for the “wanting” or “liking” of food. In brain, the
shell of NAc contributes to processes like incentive motivation
and reward learning, essential in food consumption behavior
(Michaelides et al., 2013; Resendez et al., 2013). Indeed, many
studies have shown an interaction between the NAc shell and
food intake (Will et al., 2007; van der Plasse et al., 2012; Castro
and Berridge, 2014). Though nesfatin-1 is abundantly expressed
in NAc, the role for nesfatin-1 in NAc is not clear. Here we
examine the possible role for nesfatinergic projections from NAc
in modulating hypothalamic metabolic centers.
In this study, we aim to better understand the effect of
nesfatin-1 in the VMH and NAc on food intake, gastric motility,
gastric emptying, and gastric acid output. Further, we identify a
nesfatinergic connection between NAc and VMH and its possible
role in regulating these effects.
MATERIALS AND METHODS
Animals
Adult Sprague-Dawley (SD) rats (protocol number: 0013219,
Qingdao Institute for Drug Control, Shandong, China) weighing
250 ∼ 300 g were housed under controlled illumination (12:12-h
light-dark cycle starting at 8 a.m.) and temperature (25 ± 2◦C)
and had free access to laboratory chow pellets and tap water.
Animal Guidelines were approved by the Qingdao University
Animal Care and Use Committee.
Immunofluorescence Staining of VMH after
Gastric Distension
Rats were divided randomly into 2 groups: control group
(n = 4) and gastric distension (GD) group (n = 8). The GD
was performed as described previously (Gong et al., 2013). All
rats were fasted overnight and anesthetized with Inactin (100
mg/kg, i.p.; Sigma-Aldrich Chemical, USA). Following a midline
cut on the abdomen, the fundus wall was incised and gastric
contents were washed out with warm isotonic saline. A latex
balloon (length: 3 cm, diameter: 3 cm, max volume: 12 ml)
attached to a polyethylene catheter (PE-50) was inserted into the
stomach via the incision and fixed by silk thread. The pylorus
was ligated to prevent duodenal reflux into the stomach and
change of gastric volume. The abdomen was then closed. The
polyethylene catheter was connected to an electronic barostat
(Distender Series II, G&J Electronics Inc, Canada). The balloon
was dilated to a constant pressure of 60 mm Hg for 20 s with a
4-min inter stimulus interval for 2 h. The control group received
no treatment.
Thirty minutes after GD, rats were perfusion-fixed with
4% paraformaldehyde. The brains were moved for post-fixing,
dehydrating, embedding, and sectioning. The 15-µm slices
through VMH were preincubated for 1 h with 0.01 M PBS (pH
7.4) containing 0.3% Triton X-100, and 5% goat serum, then
were incubated overnight at 4◦C with primary antibodies: rabbit
anti-c-Fos antibody (1:100, sc-8047, Santa Cruz Biotechnology,
U.S.A.) and rabbit anti-nesfatin-1 antibody (1:200, H-003-
22; Phoenix Pharmaceuticals Inc, U.S.A.). After rinsing, the
sections were incubated with goat anti-mouse (1:500, Cy3-
conjugated, 115-165-003, Jackson ImmunoResearch, U.S.A.) and
goat anti-rabbit (1:50, FITC-conjugated, 111-095-003, Jackson
ImmunoResearch, U.S.A.) fluorescent secondary antibody at
room temperature for 90 min. After washing off unbound
secondary antibodies with PBS, the sections were mounted in
Citifluor (Citifluor, London, UK). Photographs of fluorophores
were taken under a TCS SP8 two-photon laser scanning confocal
microscope (Leica Microsystems AG, Wetzler, Germany). The
mean percentage increase of c-Fos positive cells in the VMH was
calculated as: (average c-Fos positive cells in stomach-distended
rat—average c-Fos positive cells in control rat)/(average c-Fos
positive cells in control rat)× 100%.
Electrophysiological Recording in the VMH
after GD
Forty rats were prepared for GD following the protocol
mentioned above, and the electrophysiological recording
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procedure was based on the previously described method (Li
et al., 2013). The anesthetized rats were bound on a stereotaxic
frame, and craniotomy was performed around the coordinates:
−2.5 mm posterior to Bregma and 0.8 mm lateral. A four-barrel
glass microelectrode (5–15 M) was advanced in an increment
of 10 µm with the aid of hydraulic micropositioner into the
area of VMH (Bregma: P: −1.8 ∼−3.2 mm, L (R): 0.5 ∼ 1.0
mm, H: 8.5 ∼ 9.2 mm) according to the rat brain atlas of
Paxinos and Watson (Paxinos, 2007). One barrel was filled
with 0.5 M sodium acetate and 2% Pontamine sky blue to
record neural discharging, the other three barrels connected
with multi-channel pressure injector (PM2000B; Micro
Data Instrument Inc., NJ, USA) contained either: nesfatin-1
(Phoenix Pharmaceuticals, Burlingame, CA, USA), SHU9119
(an antagonist of melanocortin-3/4 receptor; Sigma-Aldrich
Chemical, MO, USA), or normal saline (NS). The drugs (<1 nl)
were superfused on the surface of neurons by a short pulse gas
pressure (1500 ms, 5.0∼ 15.0 psi).
Once the microelectrode was advanced into the VMH and a
stable firing pattern was recorded, GD stimulus was conducted.
The change of neuronal firing rate was calculated by the formula:
100% × (firing rate of neurons after treatment−firing rate
of neurons before treatment)/(firing rate of neurons before
treatment). If the mean firing frequency changed via gastric
distension by at least 20% from the mean basal level, the neurons
were divided into GD-responsive, GD-excitatory (GD-E), or GD-
inhibitory (GD-I), and no-response subcategories. Spike data was
recorded and processed using PowerLab data acquisition system
(AD Instruments Pty Ltd, Australia).
To verify the correct location of the microelectrode, an iron
deposit of pontamine sky blue was formed at the tip of the
electrode after a direct current (10 µA, 20 min). Then the
rats were perfused with 10% buffered Formalin solution and
the brains were frozen. Coronal sections were cut through
the regions of the hypothalamus, stained with neutral red,
cleared with xyline, and coverslipped. All the recording and
microinjection sites were verified under light microscope.
Food Intake and Gastric Function Test
after VMH Injection of Nesfatin-1
For direct VMH injections, a cannula was implanted. Fasted rats
were anesthetized and fixed in the stereotaxic apparatus. After
craniotomy, a stainless steel guide cannula (24 gauge, 1.5 mm
distance, Plastics One, VA, USA) was implanted into the VMH
(Bregma: P: −1.8 ∼ −3.2 mm, L (R): 0.5 ∼ 1.0 mm, H: 8.5
∼ 9.2 mm). After anchoring the cannula and sealing all skull
openings with dental acrylic, a 26-gauge obturator was placed in
the cannula. After the recovery period of 10 ∼ 14 d, the drugs
were injected with a needle (29-gauge) inserted into the cannula
and connected to a syringe by a 10 cm piece of polyethylene
tubing.
Food intake was calculated according to a previously
published method (Chen et al., 2012). Thirty cannula-implanted
rats were randomly divided into 3 groups: NS, low-dose nesfatin-
1 (10 pmol) and high-dose nesfatin-1 (100 pmol) groups. Rats
were fasted at 15:00 on the experiment day and administered
NS or nesfatin-1 in the VMH 4 h later. Next, food was
placed in the cage, and total food intake in the following 12
h was calculated by measuring the weight of food containers.
The outputs were recorded by Data Acquisition software
51,800 (Feed-Drink Monitoring System Ver. 1.31, Ugo Basile,
Italy).
The secretion of gastric acid induced by 2-deoxy-D-glucose
was studied using an acute gastric fistula method described
previously (Xia et al., 2012). Thirty rats with implanted VMH
cannulas were randomly divided into 5 groups: NS, nesfatin-1
(100 pmol), 2- DG (200 mg/kg, sc) + NS, 2-DG + nesfatin-
1, and 2-DG + nesftin-1 + SHU9119 (1 nmol) groups. Rats
were fasted for 16 h and then anesthetized with urethane (1.5
g/kg ip). After incision at the abdominal midline, the esophagus
was ligated at the gastroesophageal junction (to preserve the
vagal trunks carefully). A double-lumen cannula was inserted
into the stomach via the ligated pylorus. Basal acid secretion was
established by collection of gastric outputs in 5 ml of perfusate
every 15 min for 30 min. The gastric lumen was subsequently
rinsed with 5 ml of saline every 15 min for 120 min after drugs
were administered in the VMH or subcutaneously. The gastric
rinse solution was then titrated to pH 7.0 with 100 mM sodium
hydroxide using an automatic titrator (COM-2500; Hiranuma
Sangyo Co Ltd, Japan) for titratable acidity.
To measure gastric motility, 30 rats with implanted cannulas
were randomly divided into 5 groups: NS, nesfatin-1 (100
pmol), SHU9119 (1 nmol), nesfatin-1+ SHU9119, and nesfatin-
1 (dorsomedial hypothalamic nucleus, DMN) group. Rats in
the last group were implanted cannulas in ventral DMN as a
specificity control for VMH. Gastric motility measurement was
conducted as previously described (Guo et al., 2015). After rats
fasted overnight and anesthetized with Inactin, laparotomy was
performed to expose the stomach. For measurement of gastric
motility, a strain gauge was sutured onto the serosa of the gastric
antrum, 0.5 cm caudal from the pyloric ring. The lead wire of
the strain gauge was finally fixed at the nape of the neck with
a 2 ∼ 3 cm outside end by extending through a subcutaneous
tunnel. After recovery for 2 days, the rats were fasted overnight
and recorded the gastric motility on a polygraph (3066–23;
Chengdu Precision Instruments, Sichuan, China) by connecting
the lead wires. The phase III-like contractions were defined as
clustered potent contractions with amplitudes of more than 4
g. After achieving stable baseline recordings for at least 20 min,
nesfatin-1 or SHU9119 was administered to the VMH. Each
animal was recorded for 2 h on 2 different days. The changes
in gastric motility were evaluated by the percentage motor index
(%MI) of the motor activity in the antrum. Values of the %MI
for a 5-min period in the antrum were calculated by 100% ×
(area under the manometric trace for each 5-min period after
nesfatin-1 or vehicle injection)/(area under the manometric trace
for the 5-min period immediately before nesfatin-1 or vehicle
injection).
Gastric emptying was determined by the phenol red method
with a non-nutrient viscous solution as described previously
(Guo et al., 2015). Eighteen rats with implanted VMH cannulas
were randomly divided into 3 groups: NS, nesfatin-1 (100 pmol),
and nesfatin-1 + SHU9119 (1 nmol) groups. In the dark phase,
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FIGURE 1 | Effect of gastric distension on c-fos expression in NUCB2/nesfatin-1 positive neurons of VMH. (A,B) c-fos expression in the VMH in control (A)
and rats following gastric distension (B). (C,D) Nesfatin-1 expression in the VMH in control (C) and rats following gastric distension (D). (E,F) Double
immuno-detection of c-fos and NUCB2/nesfatin-1 in control (E) and rats following gastric distension (F). (G) Quantitative analysis of c-Fos, NUCB2/nesfatin-1, and
co-expressing of c-Fos and NUCB2/nesfatin-1 in control and distended rats. **P < 0.01 vs. control; ***P < 0.001 vs. control. White arrow points to neurons
co-expressing NUCB2/nesfatin-1 and c-fos.
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fasted rats were stimulated with nesfatin-1 or the mixture of
nesfatin-1 and SHU9119. Immediately, the animals were fed
1.5 mL of a non-nutrient viscous solution by gavage. Twenty
minutes later, rats were sacrificed and the gastric contents were
collected. Phenol red concentration was fitted to a standard
curve.
Fluorogold Retrograde Tracing
After anesthetized and mounted on a stereotaxic apparatus,
10 rats were injected 3% Fluorogold (0.2 µl, Sigma-Aldrich
Chemical, MO, USA) into the VMH. After a 7-day recovery,
the rats were perfusion-fixed with 4% paraformaldehyde. The
brains were removed for post-fixing, dehydrating, embedding,
and sectioned. Fifteen micrometers sections through NAc were
incubated overnight at 4◦C with rat anti-nesfatin-1 antibody.
After washing, the sections were incubated with goat anti-rat
fluorescent secondary antibody at room temperature for 90 min.
After washing off unbound secondary antibodies with PBS, the
sections were mounted in Citifluor (Citifluor, London, UK). The
photographs of fluorophores were taken under a TCS SP8 two-
photon laser scanning confocal microscope (Leica Microsystems
AG, Wetzler, Germany).
Electrophysiological Recording in the VMH
after Electrical Stimulation in NAc Shell
For electrical stimulation, the electrodes were implanted in the
NAc shell. Rats were anesthetized and subsequently mounted
in a stereotaxic frame. Craniotomy was performed around the
coordinates: 1.8 mm posterior to Bregma and 1.7 mm lateral.
Electrodes (David Kopf Instruments, Tujunga, CA, USA) were
placed in the NAc shell (bregma: P: 0.8 ∼ 2.8 mm, L (R): 1.0 ∼
2.5 mm, H: 5.0 ∼ 7.0 mm) and secured to the skull with dental
cement. After 3-d recovery, the electrode was attached to the
cable from a stimulator (Master-9, AMP Instruments LTD, Israel)
to stimulate nucleus with a radiofrequency output of square-wave
current impulses.
Eighty rats with implanted stimulating electrodes in NAc shell
were prepared for GD and electrophysiological recording in the
VMH following the process mentioned above. Once a neuron
in the VMH was confirmed to be the GD-responsive cell, the
direct current stimulation (20 µA, 0.5 ms and 50 Hz) was added
to NAc shell without or with the pretreatment of anti-nesfatin-1
antibody. Spike data was recorded and processed using PowerLab
data acquisition system.
Food Intake and Gastric Function Test
after Electrical Stimulation in NAc
The detailed approaches of electrode implantation, food intake,
gastric acid output, gastric motility, and emptying had been
described above. Here are the animal groups in every experiment.
In food intake test, 40 rats was randomly divided into 4
groups: control, low (20 µA), high (50 µA) current, and high
current + nesfatin-1 antibody groups. During test, the rats were
placed in the test chambers and given access to a bowl of pre-
weighed chow. The animals were electrically stimulated in the
test chamber for 1 h (from 8 to 9 p.m.), and food was weighed
at 2, 4, and 6 h after stimulation. In the high current+ nesfatin-1
antibody group, nesfatin-1 antibody was pretreated in the VMH
before the electrical stimulation.
Forty rats, implanted with electrodes in NAc shell, were used
to check the secretion of gastric acid and were randomly divided
into 5 groups: basal control, 50 µA, 2-DG (200 mg/kg, sc), 2-
DG + 50 µA, and 2-DG + 50 µA + nesfatin-1 antibody groups.
Rats in the 2nd, 4th, and 5th groups were stimulated with 50 µA
current in the NAc shell, and nesfatin-1 antibody was injected
into the VMH of rats in the 5th group.
To record the gastric motility after the electrical stimulation in
NAc shell, 30 rats were randomly divided into 3 groups: control,
50, and 50 µA+ nesfatin-1 antibody groups. Rats of the 2nd and
3rd groups received the 50 µA stimulation in the NAc shell and
SHU9119 was only given to rats of the 3rd group.
In the gastric emptying study, 30 rats were randomly divided
into 3 groups: the control group, 50 µA group, and 50 µA +
nesfatin-1 antibody groups (n= 10 in each group).
Statistics Analysis
Statistical analyses were processed with SPSS 15.0 statistics
software (SPSS Inc, Chicago, IL, USA). The results are presented
FIGURE 2 | Effect of nesfatin-1 on the firing rate of GD-responsive
neurons in the VMH. (A) GD-E neurons were mostly excited by nesfatin-1,
(B) GD-I neurons were mostly inhibited by nesfatin-1, (C) shows the change in
firing rate (%) of GD-responsive neurons in the VMH induced by nesfatin-1.
Pre-treatment with melanocortin 3/4 receptors antagonist SHU9119 inhibited
the effect of nesfatin-1. *P < 0.05 vs. NS; #P < 0.05 vs. nesfatin-1.
Frontiers in Physiology | www.frontiersin.org 5 January 2017 | Volume 7 | Article 634
Gao et al. Effects of Nesfatin-1 in VMH
as the mean ± SEM. The Kolmogorov–Smirnov test was used to
assess normal distribution. For data with a normal distribution,
two-way repeated-measures ANOVA or Student’s t-test was
applied, while data that were not normally distributed were
assessed for statistical significance using the Mann–Whitney
U-test between two groups and Kruskal–Wallis test among
more than two groups. A p < 0.05 was considered statistically
significant.
FIGURE 3 | Effect of VMH injection of nesfatin-1 on food intake and gastric function. (A) VMH injection of nesfatin-1 decreased food intake during night
period, *P < 0.05 vs. NS. (B) Nesfatin-1 attenuated gastric acid secretion induced by 2-deoxy-D-glucose, *P < 0.05 vs. NS, #P < 0.05 vs. 2-DG + NS,&P < 0.05
vs. 2-DG + nesfatin-1; (C,D) Gastric motility was inhibited by nesfatin-1, *P < 0.05 vs. NS, #P < 0.05 vs. Nesfatin-1. (E) Nesfatin-1 delayed gastric emptying of a
viscous non-caloric meal in conscious rats.*P < 0.05 vs. NS, #P < 0.05 vs. nesfatin-1.
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RESULTS
Effect of GD on the Activation of
Nesfatin-1-Expressing Neurons in the VMH
To assess activation of VMH nesfatinergic neurons following
GD, double c-fos, and NUCB2/nesfatin-1 antibody labeling
was performed. GD significantly increased the number
of c-fos immunoreactive neurons in VMH to 24.5 ± 4.9
neurons per microscope field, higher than 6.2 ± 0.8 in
control group (P < 0.001, Figures 1A,B,G). The results
of the nesfatin-1 positive cell counting between normal
and GD groups were not statistically significant (P > 0.05,
Figures 1C,D,G). Among the c-fos immunoreactive neurons,
some cells were double-labeled with the nesfatin-1 antibody
(Figures 1E,F). 8.45 ± 0.72 double-labeled neurons per
microscope field were observed in the GD group, whereas
2.01 ± 0.24 were observed in the control group (P < 0.05,
Figure 1G). Thus, GD activated nesfatinergic neurons in
VMH.
Effect of Nesfatin-1 on GD-Responsive
Neurons in the VMH
In a pre-experiment, we tested the effects of different
concentrations of nesfatin-1, including 0.1, 0.5, 1, 5, 10, 50,
100, and 200 nM, on the firing rate of VMH neurons. Our
analysis of the dose-response revealed that the half maximal
effective concentration (EC 50) of nesfatin-1 on firing rate is
approximately 10 nM.
Out of a total of 88 VMH neurons in 40 rats, 64 (72.73%)
were identified as GD-responsive neurons based on the change
of firing rate elicited by GD. Among GD-responsive neurons, 42
(47.7%) showed an increase in firing rate following GD (GD-E),
and 22 (25.0%) showed a decrease in firing rate following GD
(GD-I).
Next we assessed the effect of nesfatin-1 (10 nM, ∼1 nL) via
electrode ejection on the surface of the GD-responsive neuron.
In 42 GD-E neurons, nesfatin-1 excited 61.9% (26/42) neurons,
inhibited 16.7% (7/42), and did not affected 21.4% (9/42). Overall,
nesfatin-1 increased the firing rate of GD-E neurons by 54.48
± 15.39% (from 4.13 ± 1.21 to 6.38 ± 1.48 Hz, P < 0.05,
Figures 2A,C). Sixteen of Twenty-two (72.7%) GD-I neurons
were inhibited by nesfatin-1, resulting in a significant decrease
in the firing rate from 3.84 ± 1.10 to 2.31 ± 0.77 Hz (39.84 ±
9.18%, P < 0.05, Figures 2B,C). Further, pretreatment with the
melanocortin 3/4 receptor antagonist SHU9119 partially blocked
the effect of nesfatin-1 on the GD-responsive neurons (Figure 2).
SHU9119 alone had no effect on these neurons.
Effect of Nesfatin-1 Microinjection in VMH
on Food Intake and Gastric Function
Nesfatin-1 was microinjected into the VMH of freely moving rats
via cannula (Figure 3A). Low (10 pmol) and high (100 pmol)
FIGURE 4 | Co-localization of retrograde labeling from VMH and NUCB2/nesfatin-1 in the neurons of the shell of NAc. (A) The distribution of fluorogold
retrotracing from the VMH to the NAc, white arrows indicate FG-labeled neurons, (B) The expression of NUCB2/nesfatin-1 in the NAc, white arrows indicate
nesfatin-1positive neurons, (C) Double visualization of fluorogold and nesfatin-1 in NAc shell, white arrows indicate co-labeling of FG and nesfatin-1 in some neurons,
(D) Schematic drawing illustrating the position of immunohistochemical figures in the NAc. Scale bars, 100 µm. Ac, core of NAc.
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dose nesfatin-1 reduced cumulative food intake by 15.21 ± 2.34
and 28.63± 5.38%, respectively (P< 0.05, vs. NS group) over a 2
h period. Cumulative food intake over 4 hwas reduced in the high
dose group (P < 0.05, 80.47 ± 14.62%), but not in the low dose
group, compared with the NS group. No statistically significant
effect of nesfatin-1 on cumulative food intake was found 6 h after
drug delivery, illustrating the acute nature of nesfatin-1’s effect.
To assess the role for VMH nesfatin-1 in gastric function, we
first examined gastric acid secretion. VMH injection of nesfatin-
1 (100 pmol) had no effect on basal gastric acid secretion
(Figure 3B). However, gastric acid output induced by 2-DG was
inhibited by VMH injection of nesfatin-1 (Figure 3B). The peak
acid production was decreased by 48.63 ± 10.21% (P < 0.05, vs.
2-DG group). In the 2-DG + nesfatin-1 + SHU9119 group, the
gastric acid output was not different than the 2-DG alone group,
suggesting that nesfatin-1’s mechanism of action in the VMH
involve the melanocortin-3/4 receptor.
Next, we examined gastric motility via an implanted strain
gauge in freely moving rats. Rats receiving nesfatin-1 in VMH
showed a change in percent motor index (MI%), a measure
of gastric motility, starting 4.1 ± 0.8 min after nesfaitn-1
delivery with the peak change in MI% 15.2 ± 3.1 min following
nesfatin-1. The MI% 10–15 min after nesfatin-1 injection was
35.2 ± 8.9% lower than that of NS group at the same time
point [Figures 3Ca,b,D, P < 0.05]. Pre-treatment with 1 nmol
SHU9119 blocked the effect of nesfatin-1 (P < 0.05, vs. nesfatin-
1 group), while SHU9119 alone did not change gastric motility
[Figures 3Cc,d,D]. To investigate the site specificity of VMH
for these effects, we unilaterally injected nesfatin-1 into ventral
DMN, a nucleus close to VMH. The results showed that there
was no significant change for the gastric motility after nesfatin-
1 was administrated into DMN [P > 0.05 vs. NS group,
Figures 3Ce,D].
Lastly, we examined the effect of VMH nesfatin-1 on gastric
emptying in awake rats. VMH injection of nesfatin-1 (100 pmol)
inhibited the gastric emptying rate of a non-caloric viscous
solution to 50.5± 15.6% [P < 0.05, vs. NS group (94.4± 13.9%),
Figure 3E]. As with gastric acid secretion and gastric motility,
pre-treatment of 1 nmol SHU9119 blocked the effect of nesfatin-1
on gastric emptying (87.2± 9.2%, P< 0.05, vs. nesfatin-1 group).
Retrograde Tracing of a Nesfatin-1
Pathway from NAc to VMH
To examine projections to VMH we performed fluorogold
retrograde labeling in VMH. 7 d after fluorogold injection,
we observed abundant retrograde-labeled neurons in the shell
of NAc (Figure 4A). In the same tissue sections, nesfatin-1
immunostaining revealed several nesfatin-positive neurons in
the NAc shell (Figure 4B). Several flurogold/nesfatin-1 double
positive neurons were observed in the NAc shell (Figure 4C).
Quantitative analysis indicated approximately 43.2% fluorogold-
labeled neurons expressed nesfatin-1, and about 28.3% nesfatin-
1 positive neurons contained fluorogold. These results indicate
that nesfatinergic neurons in the NAc shell send axonal
projections to the VMH. Figure 4D illustrated the position of
immunohistochemical figures in the NAc.
Effect of NAc Stimulation on VMH
GD-Responsive Neurons
Next, we examined the physiological effects of NAc shell
modulation of VMH GD-repsonsive neurons. We applied a
20 µA current to NAc shell while simultaneously recording
single unit discharges from GD-responsive neurons in the
VMH. One hundred and three GD-responsive neurons (54
GD-E and 49 GD-I) in the VMH of 80 rats were found.
NAc shell electrical stimulation alone further excited 32 of 54
GD-E neurons (3.73 ± 0.97 to 5.53 ± 0.97 Hz, P < 0.05,
Figures 5A,C). Notably, pretreatment with nesfatin-1 antibody
in the VMH decreased the firing rate to 4.18 ± 1.02 Hz
(P < 0.05).
When GD-I neurons were examined, 26 of 49 (53.06%) were
excited by NAc shell stimulation (2.74 ± 0.71 to 5.08 ± 1.15 Hz,
p < 0.05, Figures 5B,C). Unlike GD-E neurons, the firing rate of
GD-I neurons was increased from 5.08 ± 1.15 to 6.81 ± 1.13 Hz
by the nesfatin-1 antibody (P < 0.05). Notably, injection of the
nesfatin-1 antibody, alone, to VMH did not significantly modify
the firing rate of the GD-responsive neurons (GD-E neurons: 3.34
FIGURE 5 | Effect of NAc electrical stimulation on the firing rate of
GD-responsive neurons in the VMH (n = 80). (A) GD-E neurons in the
VMH were mostly excited by NAc electrical stimulation, (B) GD-I neurons in
the VMH were mostly excited by NAc electrical stimulation. (C) Shows the
change in firing rate (%) of GD-responsive neurons in the VMH induced by NAc
electrical stimulation. Pre-treatment with NUCB2/nesfatin-1 antibody in the
VMH reduced the effect of NAc electrical stimulation on VMH GD-responsive
neurons. *P < 0.05 vs. electrical stimulation.
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± 0.95 vs. 3.73 ± 0.97 Hz; GD-I neurons: 2.86 ± 0.91 vs. 2.74 ±
0.71 Hz, p> 0.05, Figures 5A,B).
Effect of the NAc on Food Intake and
Gastric Functions
Next, we examined the effect of Nac stimulation on food intake
and gastric functions, in awake, behaving rats. Low (20 µA)
current stimulation to NAc shell had no statistically significant
effect on cumulative food intake (P > 0.05, vs. control group).
High (50 µA) current stimulation decreased cumulative food
intake at 2, 4, and 6 h to 55.88 ± 6.11, 63.73 ± 6.76, and 72.19
± 7.56% of control, respectively (P < 0.05, vs. control group,
Figure 6A). Interestingly, pretreatment with an anti-nesfatin-
1 antibody in the VMH reversed the decrease of food intake
induced by NAc stimulation (P < 0.05, vs. high current group,
Figure 6A).
Fifty microampere current stimulation to NAc shell inhibited
2-DG-induced gastric acid output, reducing gastric acid output
15 min following 2-DG from 9.16 ± 1.53 to 5.52 ± 0.88 µEq (P
< 0.05). This effect was partially blocked by administration of a
nesfatin-1 antibody to VMH (7.68 ± 0.98 µEq at 15 min, P <
0.05 vs. 2-DG+ 50 µA group, Figure 6B).
Examining the effect of NAc stimulation on gastric motility,
MI% was reduced 72.25± 9.82% by 50 µANAc shell stimulation
(P < 0.05, vs. control group). This effect was partially blocked
by a nesfatin-1 antibody, where MI% in the 50 µA + nesfatin-1
antibody group was only 94.32± 12.61% of control (P< 0.05, vs.
50 µA group, Figure 6C).
Gastric emptying was also affected by 50 µA NAc shell
stimulation, where NAc stimulation reduced emptying of the
non-caloric viscous solution by 68.36 ± 8.79% (P < 0.05,
vs. control group). Nesfatin-1 antibody pretreatment partially
blocked this effect, as gastric emptying in the 50 µA +
nesfatin-1 antibody group was 90.91 ± 14.02% control (P <
0.05, vs. 50µA current group, Figure 6D). These results illustrate
that involvement of nesfatin-1 on NAc modulation of gastric
functions via projections to the VMH.
DISCUSSION
In this study, we have demonstrated that GD activates neurons
in VMH, including some nesfatin-1-positive neurons. Nesfatin-
1 modifies the firing rate of GD-responsive VMH neurons
and VMH injection of nesfatin-1 inhibited food intake, gastric
motility, gastric acid output, and emptying. We have also shown
that electrical stimulation of the NAc affected VMH neurons and
gastric functions via nesfatinergic projections from the NAc to
the VMH. Figure 7 is a sketch of the results of the present study.
The abundant expression of nesfatin-1 in the VMH is in
line with that reported by others (Goebel et al., 2009). In this
FIGURE 6 | Effect of electrical stimulation (ES) in NAc shell on food intake and gastric function. (A) high current ES in NAc inhibited food intake, which was
reversed by antibody pretreatment in VMH. *P < 0.05 vs. Control, #P < 0.05 vs. 50 µA. (B) ES in NAc decreased gastric acid secretion induced by 2-DG, which was
partially blocked by a nesfatin-1 antibody. *P < 0.05 vs. Control, #P < 0.05 vs. 2-DG, 1P < 0.05 vs. 2-DG + 50 µA. (C) Gastric motility was decreased by ES in
NAc, *P < 0.05 vs. Control, #P < 0.05 vs. 50 µA. (D) ES in NAc delayed gastric motility, *P < 0.05 vs. Control, #P < 0.05 vs. 50 µA.
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study, we provide further evidence of the role for nesfatin-1
in VMH neurons by showing its role in GD-induced changes
in VMH. Gastric distension, mimicking the rate of gastric
emptying of a liquid meal, stimulates neural systems, and induces
negative feedback regulation of food intake (Min et al., 2011).
Bonnet et al. had reported that NUCB2/nesfatin-1 neurons of
the nucleus tractus solitarius (NTS) were sensitive to GD and
might contribute to this satiety signal (Bonnet et al., 2013). Our
group has shown that nesfatin-1 injection in PVN and ARC
also negatively modulate gastric motility (Li et al., 2013; Guo
et al., 2015). Therefore, the activation of nesfatin-1 neurons in the
VMH is a possible mechanism of GD-induced negative feedback
on appetite and food intake.
The predominant physiological effects of nesfatin-1 we
observed were an increase of firing rate in GD-E neurons and
a reduction of firing rate in GD-I neurons in VMH. These
modulatory effects likely enhance the GD-induced satiety signal
produced by hypothalamus. Thus, these results support a role for
nesfatin-1 in inhibiting food intake as proposed previously (Xu
et al., 2013; Guo et al., 2015). Previous work has noted a role
for the melanocortin-3/4 receptor (Oh et al., 2006), the oxytocin
receptor (Maejima et al., 2009), POMC and CART neurons
(Shimizu et al., 2009), or Ca2+ signaling pathway (Xia et al., 2012)
in nesfatin-1’s mechanism of action. In this study, the antagonist
of melanocortin-3/4 receptor, SHU9119, inhibited the effect of
nesfatin-1 on VMH neurons. Whether a unique, high-affinity,
receptor for nesfatin-1 is expressed in brain, or alternatively
whether nesfatin-1 exerts its effects through multiple receptors is
not known. More studies on nesfatin-1 pharmacology are needed
to fully determine its role in satiety.
We also show that delivery of nesfatin-1 to VMH suppresses
food intake, gastric acid secretion, gastric motility, and emptying.
Previous work has shown that administration of nesfatin-
1 to PVN and ARC, or to the whole brain through i.c.v.
injection, can also decrease gastric motility in rodents (Xia
et al., 2012; Bonnet et al., 2013; Li et al., 2013; Wang et al.,
2014). Watanabe et al. reported that intravenous treatment of
nesfatin-1 reduced gastric contractions and inhibited cyclical
inter-digestive migrating contractions in fasted dogs (Watanabe
et al., 2015). These studies show that central or peripheral
delivery of nesfatin-1 can negatively regulate gastric motility.
Our results indicate that not only gastric motility, but also
gastric acid secretion and emptying were inhibited by nesfatin-
1, when delivered to the VMH. These functions are similar to
leptin, which inhibits food intake, delays gastric emptying and
decreases ghrelin expression (Yarandi et al., 2011). Additionally,
two studies have found polymorphisms in NUCB2, the gene for
the nesfatin-1 precursor protein, associated with obesity (Zegers
et al., 2011, 2012). Another line of research has shown acute
oral metformin treatment delays gastric emptying, reduces food
intake through a leptin-independent mechanism, and activated
many nesfatinergic neurons, suggesting a role for nesfatin-1 in
metformin’s mechanisms of action (Rouquet et al., 2014). Taken
together, these data support targeting nesfatin-1 signaling as a
leptin-independent strategy for treating obesity.
Our results show that NAc shell express nesfatin-1, and that
those nesfatinergic neurons directly project to VMH. The NAc
FIGURE 7 | Schematic of the results of this study. Gastric distension
activates VMH neurons, including nesfatin-1-positive neurons. VMH injection
of nesfatin-1 inhibited food intake, gastric motility, gastric acid output, and
emptying. Electrical stimulation of NAc modulates VMH neurons and gastric
functions via nesfatinergic projection from the NAc to VMH.
is a key brain nucleus involved in reward processing, motivated
behaviors, and regulation of food intake (Kelley et al., 2002).
Van der Plasse et al. found that NAc shell stimulation caused
increased food intake in rats (van der Plasse et al., 2012). In
NAc shell, stimulation of GABA, mu/delta opioid or AMPA
receptors alter the feeding state of the animal (Stratford and
Kelley, 1997; Stratford et al., 1998; Duva et al., 2005; Castro and
Berridge, 2014). Supporting the role for NAc in hypothalamic
control of feeding, Duva et al. illustrated anatomical evidence
for projections between NAc shell and hypothalamus (Duva
et al., 2005). Previous work has illustrated that these connections
use primary amino acid neurotransmitters and orexin, and are
involved in regulating the hedonic value of tastes, as well as
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food intake, overall (Urstadt and Stanley, 2015). In this study,
we illustrate for the first time a nesfatinergic pathway between
NAc shell and VMH. We further show the functionality of this
pathway, as pretreatment with a nesfatin-1 antibody in the VMH
modified the effect of NAc shell electrical stimulation on GD-
responsive VMH neurons. Thus, our result suggest an important
role for nesfatin-1 in this NAc shell to VMH connection. Our
food intake and gastric function studies illustrate that these
nesfatinergic NAc shell to VMH connections are physiologically
important. Taken together, these studies confirm the involvement
of NAc shell in the regulation of food intake, which likely
involves nesfatin-1 signaling in VMH. A better understanding of
NAc-hypothalamic connections and nesfatin-1 signaling may be
useful in seeking more effective treatments for obesity and other
disorders of food intake regulation.
CONCLUSIONS
Nesfatin-1 in the VMH inhibited food intake and gastric
functions. A nesfatinergic pathway from NAc shell to VMH was
characterized and also shown to be involved in these effects.
These results illustrate a novel connection between the reward
system and metabolic regulating nuclei in the hypothalamus.
Further studies are needed to further characterize this potentially
important pathway in the regulation of appetite and gastric
functions.
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